04.08.2025 Syntropic Medical receives IRB approval for new home-based light therapy clinical trialmore about Syntropic Medical receives IRB approval for new home-based light therapy clinical trial
31.07.2025 Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalizationmore about Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
31.07.2025 AIT: Microbiomes are key to healthy and sustainable food systemsmore about AIT: Microbiomes are key to healthy and sustainable food systems
30.07.2025 Jean-Michel Quinot Appointed COO of AOP Healthmore about Jean-Michel Quinot Appointed COO of AOP Health
29.07.2025 VetMedUni: Sex-specific effects of a ketogenic diet during pregnancy on mouse offspringmore about VetMedUni: Sex-specific effects of a ketogenic diet during pregnancy on mouse offspring
29.07.2025 Pharmig: Bei Arzneimittel zu sparen, heißt die Versorgung und den Standort zu gefährdenmore about Pharmig: Bei Arzneimittel zu sparen, heißt die Versorgung und den Standort zu gefährden
28.07.2025 Lilly Österreich startet neuen Podcast „Wirkstoff Mensch“ – im Fokus: Menschen hinter medizinischen Themenmore about Lilly Österreich startet neuen Podcast „Wirkstoff Mensch“ – im Fokus: Menschen hinter medizinischen Themen
28.07.2025 MedUni Vienna: District cooling plant with innovative ice storage facility at MedUniCampus Mariannengasse goes into operationmore about MedUni Vienna: District cooling plant with innovative ice storage facility at MedUniCampus Mariannengasse goes into operation
28.07.2025 Resonate Bio Awarded the Austria Wirtschaftsservice’s DeepTech Pre-Seed Grant to Accelerate AI-NMR Innovationmore about Resonate Bio Awarded the Austria Wirtschaftsservice’s DeepTech Pre-Seed Grant to Accelerate AI-NMR Innovation
25.07.2025 University Vienna: Which signalling pathways in the cell lead to possible therapies for Parkinson's diseasemore about University Vienna: Which signalling pathways in the cell lead to possible therapies for Parkinson's disease
23.07.2025 Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencastmore about Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
23.07.2025 Eveliqure Announces Dosing of First Participants in a Phase 2b study of the ShigETEC Vaccine in Shigellosismore about Eveliqure Announces Dosing of First Participants in a Phase 2b study of the ShigETEC Vaccine in Shigellosis